Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - COST OF REVENUE
Cost of Revenue RARE - Ultragenyx Pharmaceutical Inc.
76.7 M
LAST VALUE
64.60%
2 YEAR CAGR
53.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR